Compounds > methylprednisolone

methylprednisolone and phenindione

methylprednisolone has been researched along with phenindione in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Amoura, Z; Ankri, A; Aymard, G; Cacoub, P; Costedoat-Chalumeau, N; Diquet, B; Du, LT; Piette, JC; Sevin, O; Wechsler, B1
Klein, I; Lidove, O; Papo, T; Sacré, K; Zaidan, M1

Other Studies

4 other study(ies) available for methylprednisolone and phenindione

ArticleYear
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone.
    Annals of internal medicine, 2000, Apr-18, Volume: 132, Issue:8

    Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Blood Coagulation Factors; Drug Synergism; Female; Humans; Infusions, Intravenous; International Normalized Ratio; Male; Methylprednisolone; Middle Aged; Phenindione; Prospective Studies; Protein C; Protein S; Prothrombin Time; Vitamin K

2000
"Fulminant" Behçet disease.
    Presse medicale (Paris, France : 1983), 2011, Volume: 40, Issue:11

    Topics: Administration, Oral; Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Atrophy; Azathioprine; Behcet Syndrome; C-Reactive Protein; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Emigrants and Immigrants; Female; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Myelitis, Transverse; Neurologic Examination; Phenindione; Prednisolone; Pyoderma Gangrenosum; Spinal Cord; Spinal Cord Ischemia; Tumor Necrosis Factor-alpha

2011